Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
NCT00032968 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 341
Last updated 2017-01-12
Summary
The purpose of this study is to assess buprenorphine/naloxone versus clonidine for outpatient opiate detoxification.
Conditions
- Heroin Dependence
- Morphine Dependence
- Substance Withdrawal Syndrome
Interventions
- DRUG
-
Buprenorphine/naloxone
Sponsors & Collaborators
-
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Walter Ling, M.D. · Los Angeles Treatment Research Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-01-31
- Primary Completion
- 2002-08-31
- Completion
- 2002-08-31
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
NCT00000329 ·Status: WITHDRAWN ·Phase: PHASE2
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
NCT00015340 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
NCT00015028 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
NCT00238914 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
NCT02294253 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Improved Strategies for Outpatient Opioid Detoxification
NCT01377610 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000330 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Buprenorphine in the Emergency Department
NCT03174067 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Buprenorphine/Naloxone
NCT02882412 ·Status: UNKNOWN
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3
-
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
NCT00332228 ·Status: COMPLETED ·Phase: PHASE2
-
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
NCT01717963 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
NCT00078130 ·Status: COMPLETED ·Phase: PHASE3
-
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000331 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine and Naloxone Combination Study - 10
NCT00015288 ·Status: COMPLETED ·Phase: PHASE1
-
Abuse Potential of Buprenorphine/Naloxone
NCT00149539 ·Status: TERMINATED ·Phase: PHASE2